The use of maximum SOFA score to quantify organ dysfunction/failure in intensive care.: Results of a prospective, multicentre study

被引:678
作者
Moreno, R
Vincent, JL
Matos, R
Mendonça, A
Cantraine, F
Thijs, L
Takala, J
Sprung, C
Antonelli, M
Bruining, H
Willatts, S
机构
[1] Hosp St Antonio Capuchos, Unidad Cuidados Intens Polivalente, P-1150 Lisbon, Portugal
[2] Erasme Univ Hosp, Dept Intens Care, B-1070 Brussels, Belgium
[3] Free Univ Brussels, Fac Med, Brussels, Belgium
[4] Vrije Univ Amsterdam, Med Intens Care Unit, Acad Ziekenhuis, NL-1081 HV Amsterdam, Netherlands
[5] Kuopio Univ Hosp, Dept Intens Care, SF-70210 Kuopio, Finland
[6] Hebrew Univ Jerusalem, Hadassah Med Ctr, Dept Intens Care, Jerusalem, Israel
[7] Univ Roma La Sapienza, Ist Anestesiol & Reanimaz, Rome, Italy
[8] Acad Ziekenhuis, Intens Care Unit, Rotterdam, Netherlands
[9] Bristol Royal Infirm & Gen Hosp, Directorate Anaesthesia, Bristol, Avon, England
关键词
severity of illness index; sepsis; multiple organ failure; multiple organ dysfunction syndrome; intensive care; critical care;
D O I
10.1007/s001340050931
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Objective: To evaluate the performance of total maximum sequential organ failure assessment (SOFA) score and a derived measure, delta SOFA (total maximum SOFA score minus admission total SOFA) as a descriptor of multiple organ dysfunctional/failure in intensive care. Design: Prospective, multicentre and multinational study. Setting: Forty intensive care units (ICUs) from Australia, Europe, North and South America. Patients: Data on 1,449 patients, evaluated at admission and then consecutively every 24 h until ICU discharge (11,417 records) during May 1995. Excluded from data collection were all patients with a length of stay in the ICU less than 2 days following uncomplicated scheduled surgery. Main outcome measure: Survival status at ICU discharge. Interventions:The collection of raw data necessary for the computation of a SOFA score on admission and then every 24 h, and basic demographic and clinical statistics. Measurements and main results: Mean total maximum SOFA score presented a very good correlation to ICU outcome, with mortality rates ranging from 3.2 % in patients without organ failure to 91.3 % in patients with failure of all the six organs analysed. A maximum score was reached 1.1 +/- 0.2 days after ad-mission for all the organ systems analysed. The total maximum SOFA score presented an area under the ROC curve of 0.847 (SE 0.012), which was significantly higher than any of its individual components. The cardiovascular score (odds ratio 1.68) was associated with the highest relative contribution to outcome. No independent contribution could be demonstrated for the hepatic score. No significant interactions were found. Principal components analysis demonstrated the existence of a two-factor structure that became clearer when analysis was limited to the presence or absence of organ failure (SOFA score greater than or equal to 3 points) during the ICU stay. The first factor comprises respiratory, cardiovascular and neurological systems and the second coagulation, hepatic and renal systems. Delta SOFA also presented a good correlation to outcome. The area under the receiver operating characteristic (ROC) curve was 0.742 (SE 0.017) for delta SOFA, lower than the total maximum SOFA score or admission total SOFA score. The impact of delta SOFA on prognosis remained significant after correction for admission total SOFA. Conclusions: The results show that total maximum SOFA score and delta SOFA can be used to quantify the degree of dysfunction/failure already present on ICU admission, the degree of dysfunction/failure that appears during the ICU stay and the cumulative insult suffered by the patient. These properties make it a good instrument to be used in the evaluation of organ dysfunction/failure.
引用
收藏
页码:686 / 696
页数:11
相关论文
共 65 条
  • [1] EFFICACY AND SAFETY OF MONOCLONAL-ANTIBODY TO HUMAN TUMOR-NECROSIS-FACTOR-ALPHA IN PATIENTS WITH SEPSIS SYNDROME - A RANDOMIZED, CONTROLLED, DOUBLE-BLIND, MULTICENTER CLINICAL-TRIAL
    ABRAHAM, E
    WUNDERINK, R
    SILVERMAN, H
    PERL, TM
    NASRAWAY, S
    LEVY, H
    BONE, R
    WENZEL, RP
    BALK, R
    ALLRED, R
    PENNINGTON, JE
    WHERRY, JC
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1995, 273 (12): : 934 - 941
  • [2] p55 tumor necrosis factor receptor fusion protein in the treatment of patients with severe sepsis and septic shock - A randomized controlled multicenter trial
    Abraham, E
    Glauser, MP
    Butler, T
    Garbino, J
    Gelmont, D
    Laterre, PF
    Kudsk, K
    Bruining, HA
    Otto, C
    Tobin, E
    Zwingelstein, C
    Lesslauer, W
    Leighton, A
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1997, 277 (19): : 1531 - 1538
  • [3] GLASGOW COMA SCALE SCORE IN THE EVALUATION OF OUTCOME IN THE INTENSIVE-CARE UNIT - FINDINGS FROM THE ACUTE PHYSIOLOGY AND CHRONIC HEALTH EVALUATION-III STUDY
    BASTOS, PG
    SUN, XL
    WAGNER, DP
    WU, AW
    KNAUS, WA
    [J]. CRITICAL CARE MEDICINE, 1993, 21 (10) : 1459 - 1465
  • [4] MULTIPLE ORGAN SYSTEM FAILURE AND INFECTION IN ADULT RESPIRATORY-DISTRESS SYNDROME
    BELL, RC
    COALSON, JJ
    SMITH, JD
    JOHANSON, WG
    [J]. ANNALS OF INTERNAL MEDICINE, 1983, 99 (03) : 293 - 298
  • [5] The effects of ibuprofen on the physiology and survival of patients with sepsis
    Bernard, GR
    Wheeler, AP
    Russell, JA
    Schein, R
    Summer, WR
    Steinberg, KP
    Fulkerson, WJ
    Wright, PE
    Christman, BW
    Dupont, WD
    Higgins, SB
    Swindell, BB
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1997, 336 (13) : 912 - 918
  • [6] Quantification of organ dysfunction: Seeking standardization
    Bernard, GR
    [J]. CRITICAL CARE MEDICINE, 1998, 26 (11) : 1767 - 1768
  • [7] BERNARD GR, 1995, AM J RESP CRIT CARE, V151, pA323
  • [8] AMERICAN-COLLEGE OF CHEST PHYSICIANS SOCIETY OF CRITICAL CARE MEDICINE CONSENSUS CONFERENCE - DEFINITIONS FOR SEPSIS AND ORGAN FAILURE AND GUIDELINES FOR THE USE OF INNOVATIVE THERAPIES IN SEPSIS
    BONE, RC
    BALK, RA
    CERRA, FB
    DELLINGER, RP
    FEIN, AM
    KNAUS, WA
    SCHEIN, RMH
    SIBBALD, WJ
    ABRAMS, JH
    BERNARD, GR
    BIONDI, JW
    CALVIN, JE
    DEMLING, R
    FAHEY, PJ
    FISHER, CJ
    FRANKLIN, C
    GORELICK, KJ
    KELLEY, MA
    MAKI, DG
    MARSHALL, JC
    MERRILL, WW
    PRIBBLE, JP
    RACKOW, EC
    RODELL, TC
    SHEAGREN, JN
    SILVER, M
    SPRUNG, CL
    STRAUBE, RC
    TOBIN, MJ
    TRENHOLME, GM
    WAGNER, DP
    WEBB, CD
    WHERRY, JC
    WIEDEMANN, HP
    WORTEL, CH
    [J]. CRITICAL CARE MEDICINE, 1992, 20 (06) : 864 - 874
  • [9] A CONTROLLED CLINICAL-TRIAL OF HIGH-DOSE METHYLPREDNISOLONE IN THE TREATMENT OF SEVERE SEPSIS AND SEPTIC SHOCK
    BONE, RC
    FISHER, CJ
    CLEMMER, TP
    SLOTMAN, GJ
    METZ, CA
    BALK, RA
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1987, 317 (11) : 653 - 658
  • [10] PREDICTING OUTCOME AMONG INTENSIVE-CARE UNIT PATIENTS USING COMPUTERIZED TREND ANALYSIS OF DAILY APACHE-II SCORES CORRECTED FOR ORGAN SYSTEM FAILURE
    CHANG, RWS
    JACOBS, S
    LEE, B
    [J]. INTENSIVE CARE MEDICINE, 1988, 14 (05) : 558 - 566